Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More
Xconomy
AUGUST 5, 2016
Just as many M&A rumors flame out as lead to deals, of course, but the news was enough to give Biogen’s stock price a big bump, and ignite chatter about what a sale of one of biotech’s heavyweights would mean, particularly for the Boston area. The rumors boosted Biogen’s sinking stock price nearly 10 percent.
Let's personalize your content